
Assenagon Asset Management S.A. Raises Stock Holdings in Travere Therapeutics, Inc. $TVTX
Assenagon Asset Management S.A. lifted its stake in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 347.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 417,742 shares of the company’s stock after acquiring an additional 324,387 shares during the [...]






